PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. Genetics & Applications, [S. l.], v. 2, n. 2, p. 51–56, 2018. DOI: 10.31383/ga.vol2iss2pp51-56. Disponível em: https://genapp.ba/editions/index.php/journal/article/view/108. Acesso em: 14 nov. 2026.